Skip to main content
Equibles
CERT logo

CERT · Certara, Inc. · Metrics

Track CERT — free

Use CERT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.63 -0.11 (-1.42%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Customer concentration — top 10 customers 24% of revenue

10 customers — 24% of revenue (the year ended December 31, 2025)

“Our ten largest customers accounted for 24% of revenues for the year ended December 31, 2025.”
View the 10-K filed Feb 26, 2026
Market Cap
$1.19B
Shares
152.54M

CERT metrics

78 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.74
Market cap
$1.19B

Price action

20 metrics
Price change (1W)
-4.9%
Price change (30D)
-1.6%
Price change (3M)
+47.9%
Price change (6M)
+12.5%
Price change (YTD)
-9.9%
Price change (1Y)
-25.0%
Trailing year
Price change (5Y)
-79.0%
52-week high
$13.60
52-week low
$4.48
Change from 52-week high
-41.6%
Change from 52-week low
+77.2%
Annualized volatility
59.7%
Annualized volatility (3M)
60.6%
Beta
0.8
RSI (14D)
48.7
Price vs SMA 50
+4.3%
Price vs SMA 200
+10.0%
Avg volume (3M)
3.87M
Relative volume
0.3
Average dollar volume
$26.77M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
152.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.1×
reciprocal yield 32.4%
EV / EBITDA
16.8×
reciprocal yield 6.0%
EV / EBIT
1,062.8×
reciprocal yield 0.1%
P / sales
2.8×
reciprocal yield 35.3%
P / book
1.2
reciprocal yield 81.1%
FCF yield
—
TTM · current market cap
Buyback yield
6.3%
P / FCF
—
P / operating cash flow
14.4
reciprocal yield 7.0%
Earnings yield
-5.7%

Historical valuation

8 metrics
P / E historical average (3Y)
193.2×
reciprocal yield 0.5%
P / E historical average (5Y)
193.2×
reciprocal yield 0.5%
EV / revenue historical average (3Y)
5.3×
reciprocal yield 18.7%
EV / revenue historical average (5Y)
7.0×
reciprocal yield 14.4%
EV / EBIT historical average (3Y)
247.4×
reciprocal yield 0.4%
EV / EBIT historical average (5Y)
217.6×
reciprocal yield 0.5%
EV / EBITDA historical average (3Y)
1,057.0×
reciprocal yield 0.1%
EV / EBITDA historical average (5Y)
673.8×
reciprocal yield 0.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
0.3%
Trailing 12 months
Net margin
-16.3%
Gross profit (TTM)
—
Operating profit (TTM)
$1.22M
Net income (TTM)
−$68.40M
Trailing 12 months
Diluted EPS (TTM)
$-0.45
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$5.37

Growth

11 metrics
Revenue growth YoY
+1.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$420.66M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.7%
Revenue CAGR (5Y)
+11.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+1.2%
FCF CAGR (5Y)
+16.6%

Quality

14 metrics
Return on equity
-7.1%
Return on assets
-4.9%
Debt / equity
0.3
Current ratio
2.6
EBITDA (TTM)
$77.52M
Free cash flow (TTM)
—
Quick ratio
2.6
Interest coverage
0.1
Net debt / EBITDA
1.4
Return on invested capital
—
Trailing 12 months
Net cash
−$107.70M
Latest balance sheet
Cash & equivalents
$184.14M
Total assets
$1.40B
Total debt
$291.84M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$82.86M
Capital expenditures (TTM)
$2.48M
R&D (TTM)
$43.54M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
10.3%
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
243
13F filer change QoQ
-13
Institutional ownership
88.3%

Short interest

3 metrics
Short interest
16.5%
Latest settlement · 6.2 days to cover
Days to cover
6.2d
Short-squeeze score
77 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1827090 CUSIP 15687V109 13F (30d) 156 filings 156 filers Visit website Investor relations